Introduction
The Achilles tendon (AT) is the strongest tendon in the human body [
1] and is affected by various types of extrinsic (traumatic and overuse conditions) and intrinsic (gender, age, genetics) causes [
2]. A recent study [
3] found that Achilles tendinopathy is one of the most common overuse injury in young active adults. Furthermore, spontaneous rupture has become more common recently due to an increase in the sporting activity by the middle-aged population [
4,
5].
In cases of acute AT ruptures, physical examination has shown similar sensitivity in diagnostics to magnetic resonance imaging (MRI); however, in cases of ambiguous presentations and subacute or chronic injuries of the AT, MRI still represents the gold standard in diagnostics [
6]. A MRI can provide important information about the pathological state of the AT as well as associated pathologies. Furthermore, in a study by Khan et al. grading of the AT by baseline MRI appearance was associated with clinical outcome at the 12-month follow-up [
7].
However, to date, no MRI score exists that utilizes the outstanding soft tissue contrast of MRI to semiquantify AT injuries by the morphological appearance in a standardized manner. Instead, most recent studies have attempted to align irregularly applied nomenclatures for different AT pathologies, such as achillodynia, tendinopathy and tendinosis [
2,
8]. Therefore, we aimed to develop a new comprehensive MRI score that includes the relevant parameters for clinical and radiological physicians in a standardized, semiquantitative manner (meaning that different qualitative and quantitative parameters are scaled and contribute to an overall score of 0–100 points), comparable e.g. to the MOCART 2.0 score [
25]. Semiquantitative MRI-based assessments may enable identification of AT tissue pathologies that are relevant to important clinical and structural endpoints.
Therefore, the purpose of this study was to develop and introduce the MRI-based, semiquantitative Vienna morphological Achilles tendon score (VIMATS), to evaluate its reproducibility in patients with AT injuries, to assess its potential to differentiate between patients and healthy volunteers and to assess its correlation with a clinical score for the first time.
Discussion
This study introduces the newly developed semiquantitative, MRI-based Vienna morphological Achilles tendon score (VIMATS) and describes the initial experience in assessing patients with AT pain.
The intent of this study was to develop and provide an easy and reproducible semiquantitative assessment tool for AT disorders that would also find widespread acceptance among physicians who are not experts in the field of MRI and can be used in daily clinical routine. Therefore, only morphological standard sequences were used for the evaluation of the score. Furthermore, we kept the overall scan time of the MRI protocol to about 15 min, which is feasible in a clinical or clinical trial setting.
Schweitzer and Karasick proposed a clinical radiological tendinopathy classification of 7 relevant main groups including a total of 11 subgroups with different imaging characteristics [
1]. The present score does not try to classify a specific pathology into a nomenclature. Rather, by combining several morphological characteristics, injuries of the AT can be semiquantitatively scored from 0 to 100 points in a standardized manner. This might help in the future to easily compare the morphological results of various treatment procedures.
Based on our new VIMATS excellent interobserver (0.946) and intraobserver agreement (0.925) was found. As explained before, the score consists of four different parameters: (1) thickness, (2) continuity, (3) signal and (4) associated pathologies, with four subgroups of possible associated pathologies.
Normal tendon thickness is described to be less than 7 mm in healthy asymptomatic volunteers [
10,
16]. With ongoing degeneration of the AT, swelling of the tendon occurs. Therefore, the variable thickness was chosen as a substantial parameter of the VIMAT score, counting for 30% of the maximum score. Some authors suggested measuring the volume of the AT [
17]; however, this requires appropriate software tools.
The continuity of the tendon is the most important factor for the functionality of the AT, and therefore, we weighted this variable also with possible 30 points within the VIMAT score. The most typical location for a rupture of the AT is 2–6 cm proximal of the calcaneal insertion, because there is a hypovascular zone with reduced nutrition of the tissue [
18]. It is important for the functionality as well as the clinical outcome if there is a complete or a partial tear. A possible pitfall when assessing interstitial tears of the AT is the normal fascicular anatomy or small intratendinous vessels of the AT. These may be visible as a single hyperintense line and can mimic an interstitial tear but do not show fluid-like signal intensity and do not have a pathological value [
1,
10].
The signal intensity counts for another 20% (20 points) of the total score. Due to the very short relaxation times of the tendon fibers, the healthy AT should be low of signal and almost dark; however, besides the fact of free water within the tendon as well as change in fiber orientation (magic angle effect) as a cause of rupture, a variety of tendon degenerations (which can be hypoxic, hyaline, myxoid, fibrinoid, or fatty [
2,
19]) lead to an increase in T2 relaxation times and are seen as a precursor for a weakening of the AT structure. The relative high percentage of 35% of asymptomatic tendons with hyperintense intratendinous signal intensity in the control group might be due to neovascularization and is consistent with the literature [
20].
The variables thickness, continuity and signal intensity account together for 80% of the total VIMATS. This seems to be justified in consideration of the fact that these variables showed the highest correlation with clinical scoring.
Furthermore, the VIMAT score takes different associated pathologies into account the presence of which is a cause for or expression of inflammation or degenerative processes, and have a negative impact on the status of the AT, and therefore, on the total score of the individual VIMATS (up to minus 20 points).
The Haglund exostosis is also known as “pump bump” [
14] and ends in a circle of injury, response to injury and reinjury [
1]. As a result of chronic irritation, the calcaneal tuberosity may enlarge, which further irritates the retro-Achilles bursa and the AT itself, which again leads to an irritation of the calcaneal tuberosity. Therefore, it may also be associated with retrocalcaneal bursitis or insertional tendinitis [
21]; however, in our small cohort of patients and volunteers no difference was found in the incidence of the Haglund deformity.
The insertional tendonitis is common in runners and frequently leads to the development of calcifications, bone spurs and bone cysts in the tendon insertion at the calcaneus [
1,
14], often seen as the source for back heel pain. Likewise, the calcaneal bone marrow edema as a result of direct trauma or chronic failure load.
Paratendonitis and peritendinitis are frequently used synonymously and refer to the inflammatory change of the paratendon. With an acute peritendinitis, the tendon maintains its normal size and shape, whereas a chronic peritendinitis leads to a thickening of the tendon [
14]. Due to the increased fluid content in the inflamed tissue, a peripheral signal intensity increase can be seen on T2-weighted images.
In the case of degenerative AT changes, edema of Karger’s fat pad and concomitant retrocalcaneal bursitis are often present. A subcutaneous bursitis often occurs and its presence usually indicates local trauma or inflammation.
Regarding the clinical value of the presented score, we were able to initially show that the individual variables (with exception of the incidence of the Haglund exostosis) of the VIMATS as well as the total VIMATS itself differed significantly between patients and healthy volunteers. Furthermore, the initial results for correlation with clinical scoring yielded moderate results; however, to clarify the clinical value and the accuracy of the newly created VIMATS, some future work has to be done. Numerically larger as well as more accurately defined patient cohorts (for example classification of AT pathologies according to the classification proposed by Schweitzer and Karasick) need to be investigated using the VIMATS. Furthermore, follow-up studies using the VIMATS on different treatment strategies will strengthen its clinical implication. Several studies have demonstrated the feasibility of different new quantitative MRI methods for the evaluation of the biochemical composition and ultrastructure of the AT [
22,
23]. Correlation of the VIMAT score with these new quantitative MRI techniques will further strengthen the clinical value of the VIMAT score in the assessment of AT pathologies.
A limiting factor of this study is the comparatively small number of patients enrolled. To confirm the validity of the assessed parameters and the VIMAT score itself, correlation with a gold standard, such as intraoperative reports or histology would be necessary. Clinical scoring using the ATRS was only available in 20 patients because this was done retrospectively in telephone interviews, which is a major limitation of this study. Furthermore, for this initial study only preoperative patients were included. Of course, the usability of this score in postoperative patients needs to be proven in future studies. Since most of the available MRI scanners have field strengths lower than 3.0 T, a MRI scanner with a field strength of 1.5 T, for example, may have a negative impact on the validity and reproducibility of the VIMATS; however, in a more recent study, the MRI evaluation of joints and tendons of the hindfoot did not reveal any significant differences between low-field and high-field MRI [
24]. Furthermore, no contrast agent was added to the MRI protocol. Contrast enhancement might have increased the diagnostic accuracy, especially when an inflammation process is present; however, standard administration of contrast agent would reduce the clinical applicability of this score. Nevertheless, if an inflammation process is suspected decision for administration of contrast agent can be done in each case individually.
In conclusion this study demonstrated that the VIMATS is a straightforward (applicable also for physicians who are not experts in the field of MRI imaging), fast (short and cost-efficient MRI protocol), and reproducible MRI score which was able to distinguish between patients and volunteers and showed moderate correlation with clinical scoring. Further evaluation of the clinical validity of the presented MRI scoring system should be the subject of additional future prospective studies. This might in the future provide physicians with a powerful tool to longitudinally monitor patients before and after surgical or conservative treatment and might help, e.g. to predict patients who are at risk of rupture or rerupture of the Achilles tendon.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.